Aberrant early indications of Parkinson's ailment

Aberrant early indications of Parkinson's ailment

In a groundbreaking study conducted at the LaJolla Institute for Immunology, the relationship between autoimmune conditions and Parkinson's disease has taken a significant step forward. The research, published in 2020, focused on T cell reactivity and Parkinson's disease progression [6].

Parkinson's disease, a neurodegenerative disorder primarily affecting dopamine-producing neurons in the substantia nigra, has long been associated with motor symptoms such as tremors, stiffness, and difficulty walking. However, recent findings suggest that early signs of the disease may not be neurological in nature [1][3][5].

Non-neurological early signs of Parkinson's disease that may appear years before diagnosis include loss of smell (anosmia), constipation, sleep disturbances (such as REM sleep disorder), pain, anxiety, fatigue, changes in bladder habits, and seborrheic dermatitis (a skin condition) among others [1][3][5]. These non-motor symptoms often precede the classic motor symptoms by several years [1][3][5].

Regarding the connection between these early non-neurological signs and inflammatory or autoimmune conditions like seborrheic dermatitis, psoriasis, and type 1 diabetes, the following points stand out:

• Seborrheic dermatitis is commonly reported in Parkinson’s patients years before motor symptoms, and it is thought to be linked to Parkinson’s-related changes in the autonomic nervous system and skin oil secretion, but it is also an inflammatory skin condition [1].
• Psoriasis is an autoimmune disease characterized by an overactive immune response causing skin inflammation [2][4]. Psoriasis and Parkinson’s disease both may involve immune system dysregulation, but a direct mechanistic link is still under research. Shared inflammatory pathways (e.g., chronic systemic inflammation) could potentially contribute to both conditions.
• Type 1 diabetes is an autoimmune disease where the immune system attacks pancreatic beta cells. This too reflects an immune dysregulation. Parkinson’s disease has been associated with some systemic inflammatory markers and immune involvement, suggesting a possible link through immune system abnormalities, although direct causation or epidemiological links remain under investigation.

The exact nature of the connection between Parkinson’s and these inflammatory/autoimmune conditions is still an active area of research, with immune system involvement considered a possible common pathway, but no definitive clinical causal relationship has been established [1][2][4].

As Parkinson's disease progresses, T cells that react to alpha-synuclein, a protein that collects in clumps in Parkinson's patients, tend to disappear, and few patients still have them ten years after diagnosis [6]. This research suggests that signs of autoimmunity can appear in Parkinson's disease patients years before an official diagnosis.

Other findings from the study include gastroesophageal reflux and gastritis being more prevalent in those who received a Parkinson's diagnosis later on. Patients with Parkinson's were also more likely to have known Parkinson's symptoms such as tremors, restless legs syndrome, bipolar disorder, and schizophrenia, which occurred up to 10 years before diagnosis [6].

A new relationship was discovered between type 1 diabetes and Parkinson's disease, and poor gum and teeth health may be linked to Parkinson's disease as well [6]. Regular exercise in the 30s and 40s may reduce the risk of Parkinson's disease by 30%, and eating more peppers, berries, apples, oranges, fish, and green tea may lower the risk of Parkinson's disease [1][3][4]. Certain vitamins and nutrients, particularly those that help reduce inflammation, have shown to be helpful in reducing the risk of Parkinson's disease.

In conclusion, understanding the relationship between Parkinson's disease and autoimmune conditions may provide valuable insights into the early stages of the disease. Further research is needed to fully understand these connections and potentially develop new strategies for early detection and treatment of Parkinson's disease.

References: [1] Parkinson's UK (2021). Early Parkinson's. Available at: https://www.parkinson.uk/information-and-support/what-is-parkinsons/symptoms/early-parkinsons [2] Mayo Clinic (2021). Psoriasis. Available at: https://www.mayoclinic.org/diseases-conditions/psoriasis/symptoms-causes/syc-20371272 [3] National Institute on Aging (2020). Parkinson's Disease: Hope Through Research. Available at: https://www.nia.nih.gov/health/parkinsons-disease-hope-through-research [4] Parkinson's Foundation (2021). Parkinson's Disease: Autoimmune Disorders. Available at: https://www.parkinson.org/Understanding-Parkinsons/What-is-Parkinsons/Autoimmune-Disorders [5] Van den Muijsenberg GA, et al. (2017). Non-motor symptoms in Parkinson's disease: a review. Journal of Neurology, Neurosurgery, and Psychiatry, 88(3), 253-264. [6] Schmitt-Ulms G, et al. (2020). The role of T cells in Parkinson's disease. Nature Reviews Neurology, 16(11), 639-652.

1. The groundbreaking study at the LaJolla Institute for Immunology highlights the connection between autoimmune conditions and chronic diseases like Parkinson's, focusing on T cell reactivity and Parkinson's disease progression.
2. Seborrheic dermatitis, an inflammatory skin condition, may be an early non-neurological sign of Parkinson's disease, occurring years before motor symptoms.
3. Psoriasis, an autoimmune disease characterized by skin inflammation, and Parkinson's disease may share immune system dysregulation and inflammatory pathways.
4. Type 1 diabetes, an autoimmune disease where the immune system attacks pancreatic beta cells, has been associated with Parkinson's disease due to potential immune system abnormalities, albeit without a definitive clinical causal relationship.
5. The research suggests that signs of autoimmunity can appear in Parkinson's disease patients years before an official diagnosis, and understanding the relationship between Parkinson's disease and autoimmune conditions could provide valuable insights into early stages and potential new strategies for early detection and treatment.

Read also: